Lexicon Pharmaceuticals (LXRX) Institutional Ownership $1.15 +0.02 (+1.77%) Closing price 04:00 PM EasternExtended Trading$1.14 0.00 (-0.43%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lexicon Pharmaceuticals (NASDAQ:LXRX)CurrentInstitutional OwnershipPercentage74.70%Number ofInstitutional Buyers(last 12 months)50TotalInstitutional Inflows(last 12 months)$37.52MNumber ofInstitutional Sellers(last 12 months)18TotalInstitutional Outflows(last 12 months)$40.02M Get LXRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexicon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data LXRX Institutional Buying and Selling by Quarter Lexicon Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/18/2025 Hudson Bay Capital Management LP27,010$26K0.0%N/A0.007% 8/15/2025 Hudson Bay Capital Management LP27,010$26K0.0%N/A0.007% 8/15/2025 Boothbay Fund Management LLC56,120$53K0.0%-87.7%0.015% 8/15/2025 Bank of America Corp DE32,097$30K0.0%-66.7%0.009% 8/14/2025 Cerity Partners LLC206,279$195K0.0%+21.1%0.057% 8/13/2025 Invesco Ltd.420,700$398K0.0%+47.2%0.116% 8/12/2025 XTX Topco Ltd66,276$63K0.0%+431.4%0.018% 8/12/2025 Catalyst Funds Management Pty Ltd53,700$51K0.0%N/A0.015% 8/8/2025 Geode Capital Management LLC2,377,694$2.25M0.0%-35.6%0.658% 8/7/2025 Monaco Asset Management SAM531,600$503K0.1%-27.6%0.147% Get the Latest News and Ratings for LXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/6/2025 Savant Capital LLC69,578$66K0.0%+33.2%0.019% 7/31/2025 R Squared Ltd29,559$28K0.0%N/A0.008% 7/25/2025 Vanguard Personalized Indexing Management LLC65,330$62K0.0%+77.8%0.018% 7/15/2025 Compagnie Lombard Odier SCmA330,000$312K0.0%+200.0%0.091% 6/27/2025 Goldman Sachs Group Inc.355,152$164K0.0%-34.3%0.098% 5/29/2025 Rhumbline Advisers137,230$63K0.0%-10.4%0.038% 5/21/2025 Acadian Asset Management LLC573,688$263K0.0%N/A0.159% 5/16/2025 Goldman Sachs Group Inc.355,152$164K0.0%-34.3%0.098% 5/16/2025 AQR Capital Management LLC1,173,225$541K0.0%N/A0.325% 5/15/2025 Nantahala Capital Management LLC460,850$212K0.0%-93.0%0.127% 5/15/2025 Siren L.L.C.3,516,214$1.62M0.1%-91.0%0.973% 5/14/2025 Ieq Capital LLC177,302$82K0.0%N/A0.049% 5/12/2025 Invesco Ltd.285,759$132K0.0%+173.5%0.079% 5/9/2025 Deutsche Bank AG94,394$43K0.0%-70.1%0.026% 5/9/2025 Charles Schwab Investment Management Inc.1,150,771$530K0.0%-3.4%0.318% 5/8/2025 Monaco Asset Management SAM734,148$338K0.1%N/A0.203% 5/6/2025 Pinnacle Associates Ltd.54,180$25K0.0%-96.2%0.015% 5/1/2025 CWM LLC105,504$49K0.0%+9,228.4%0.043% 4/30/2025 Cerity Partners LLC170,387$79K0.0%+76.5%0.069% 4/28/2025 Straight Path Wealth Management62,666$29K0.0%N/A0.025% 4/16/2025 Wealth Enhancement Advisory Services LLC69,207$32K0.0%N/A0.028% 4/10/2025 Hennion & Walsh Asset Management Inc.830,054$382K0.0%-3.8%0.337% 3/18/2025 California State Teachers Retirement System195,215$144K0.0%+29.9%0.079% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC353,508$261K0.0%+193.6%0.144% 2/17/2025 Woodline Partners LP229,376$169K0.0%-81.1%0.093% 2/17/2025 Tang Capital Management LLC850,268$628K0.0%+750.3%0.345% 2/17/2025 Point72 Asset Management L.P.8,988,421$6.64M0.0%+630.7%3.650% 2/17/2025 Deutsche Bank AG315,659$234K0.0%+378.0%0.128% 2/17/2025 Bank of America Corp DE136,407$101K0.0%+27.4%0.055% 2/17/2025 Bayesian Capital Management LP42,000$31K0.0%N/A0.017% Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again.2/14/2025 Jane Street Group LLC220,264$163K0.0%+158.0%0.089% 2/14/2025 Schonfeld Strategic Advisors LLC7,558,621$5.58M0.0%+301.5%3.070% 2/14/2025 Nantahala Capital Management LLC6,604,150$4.88M0.2%+186.6%2.682% 2/14/2025 Northern Trust Corp1,308,651$966K0.0%+14.4%0.531% 2/14/2025 Boothbay Fund Management LLC480,822$355K0.0%N/A0.195% 2/14/2025 Virtus ETF Advisers LLC425,269$314K0.1%+136.3%0.173% 2/14/2025 Price T Rowe Associates Inc. MD77,502$57K0.0%-33.9%0.031% 2/14/2025 Stifel Financial Corp112,853$83K0.0%+117.0%0.046% 2/13/2025 Barclays PLC243,316$180K0.0%+25.5%0.099% 2/13/2025 Renaissance Technologies LLC51,141$38K0.0%N/A0.021% 2/13/2025 Invesco Ltd.104,494$77K0.0%+60.6%0.042% 2/13/2025 Cerity Partners LLC96,512$71K0.0%+328.7%0.039% 2/12/2025 RPO LLC44,242$33K0.0%N/A0.018% 2/12/2025 Alliancebernstein L.P.246,121$182K0.0%-9.9%0.100% 2/12/2025 Wellington Management Group LLP747,996$552K0.0%+2.1%0.304% 2/11/2025 Virtu Financial LLC88,982$66K0.0%N/A0.036% 2/11/2025 Teacher Retirement System of Texas65,415$48K0.0%+60.3%0.027% 2/10/2025 Swiss National Bank426,600$315K0.0%+34.4%0.173% 2/6/2025 Arizona State Retirement System62,976$47K0.0%+34.4%0.026% 2/6/2025 Charles Schwab Investment Management Inc.1,191,091$880K0.0%-16.0%0.484% 1/15/2025 Hennion & Walsh Asset Management Inc.863,255$638K0.0%+18.1%0.351% 11/19/2024 Barclays PLC193,873$304K0.0%+391.6%0.079% 11/16/2024 Geode Capital Management LLC3,523,971$5.53M0.0%+8.4%1.431% 11/15/2024 Barclays PLC193,873$304K0.0%+391.6%0.079% 11/15/2024 XTX Topco Ltd80,423$126K0.0%N/A0.033% 11/15/2024 Jane Street Group LLC85,361$134K0.0%-85.9%0.035% 11/15/2024 State Street Corp2,471,215$3.88M0.0%+6.8%1.004% 11/15/2024 Point72 Asset Management L.P.1,230,050$1.93M0.0%-70.2%0.500% 11/15/2024 Atom Investors LP77,733$122K0.0%N/A0.032% 11/14/2024 Braidwell LP801,584$1.26M0.0%-90.3%0.326% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC120,387$189K0.0%N/A0.049% 11/14/2024 BBR Partners LLC470,000$738K0.1%+74.1%0.191% 11/13/2024 BNP Paribas Financial Markets31,853$50K0.0%+71.2%0.013% 11/13/2024 FMR LLC49,867,042$78.29M0.0%+28.9%20.251% 11/12/2024 Charles Schwab Investment Management Inc.1,417,295$2.23M0.0%+4.3%0.576% 11/9/2024 Intech Investment Management LLC73,440$115K0.0%N/A0.030% 10/25/2024 Pinnacle Associates Ltd.1,730,821$2.65M0.0%+0.9%0.703% 10/25/2024China Universal Asset Management Co. Ltd.69,527$109K0.0%+63.7%0.028% 10/23/2024 Hennion & Walsh Asset Management Inc.731,138$1.15M0.1%+34.7%0.297% 10/11/2024 Compagnie Lombard Odier SCmA100,000$157K0.0%+6.4%0.041% 10/3/2024 SG Americas Securities LLC46,090$72K0.0%+107.6%0.019% 8/20/2024 Nantahala Capital Management LLC2,304,150$3.87M0.2%N/A0.936% 8/19/2024 Point72 Asset Management L.P.4,121,191$6.92M0.0%+605.2%1.674% 8/15/2024CVI Holdings LLC20,000$34K0.0%N/A0.008% 8/15/2024 The Manufacturers Life Insurance Company49,957$84K0.0%+40.5%0.020% 8/14/2024 Great Point Partners LLC30,000$50K0.0%N/A0.012% 8/14/2024 Marshall Wace LLP1,190,448$2M0.0%+138.5%0.483% 8/9/2024 Dimensional Fund Advisors LP76,086$128K0.0%+52.3%0.031% 8/5/2024 Victory Capital Management Inc.45,341$76K0.0%+44.5%0.018% 8/5/2024 BBR Partners LLC270,000$454K0.0%+800.0%0.110% What Are Some Strategies to Help Lower RMD Taxes? (Ad)Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.Click here to see the six strategies and get your free advisor matches today.8/1/2024 Rhumbline Advisers152,785$257K0.0%+13.3%0.062% 7/30/2024 Pinnacle Associates Ltd.1,715,831$2.88M0.0%-1.8%0.697% 7/29/2024 Principal Financial Group Inc.22,759$38K0.0%+116.1%0.009% 7/26/2024 Bank of New York Mellon Corp401,908$675K0.0%+37.6%0.163% 7/20/2024 Hennion & Walsh Asset Management Inc.542,899$912K0.0%N/A0.220% 5/20/2024 Virtu Financial LLC43,591$105K0.0%N/A0.018% 5/16/2024 BVF Inc. IL1,686,924$4.05M0.1%-93.1%0.685% 5/14/2024Boulder Hill Capital Management LP256,400$615K0.3%N/A0.104% 5/10/2024 Vanguard Group Inc.6,401,225$15.36M0.0%+7.0%2.600% 5/7/2024 SG Americas Securities LLC19,269$46K0.0%-56.0%0.008% (Data available from 1/1/2016 forward) LXRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LXRX shares? During the previous two years, 78 institutional investors and hedge funds held shares of Lexicon Pharmaceuticals. The most heavily invested institutionals were FMR LLC ($78.29M), Vanguard Group Inc. ($15.36M), Point72 Asset Management L.P. ($6.64M), Schonfeld Strategic Advisors LLC ($5.58M), BVF Inc. IL ($4.05M), State Street Corp ($3.88M), and Geode Capital Management LLC ($2.25M).Learn more on Lexicon Pharmaceuticals' institutional investors. What percentage of Lexicon Pharmaceuticals' stock is owned by institutional investors? 74.70% of Lexicon Pharmaceuticals' stock is owned by institutional investors. Learn more on LXRX's institutional investor holdings. Which institutional investors have been buying Lexicon Pharmaceuticals' stock? Of the 70 institutional investors that purchased Lexicon Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($11.30M), FMR LLC ($11.18M), Nantahala Capital Management LLC ($6.60M), Schonfeld Strategic Advisors LLC ($5.68M), BVF Inc. IL ($4.44M), AQR Capital Management LLC ($1.17M), and Hennion & Walsh Asset Management Inc. ($863.26K). How much institutional buying is happening at Lexicon Pharmaceuticals? Institutional investors have bought a total of 37,395,703 shares in the last 24 months. This purchase volume represents approximately $37.52M in transactions. Which of Lexicon Pharmaceuticals' major shareholders have been selling company stock? Of the 18 institutional investors that sold Lexicon Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Siren L.L.C. ($35.40M), Braidwell LP ($7.49M), Nantahala Capital Management LLC ($6.14M), Point72 Asset Management L.P. ($2.89M), Pinnacle Associates Ltd. ($1.37M), Geode Capital Management LLC ($1.31M), and Woodline Partners LP ($982.55K). How much institutional selling is happening at Lexicon Pharmaceuticals? Institutional investors have sold a total of 57,756,155 shares in the last 24 months. This volume of shares sold represents approximately $40.02M in transactions. Related Companies CLDX Major Shareholders NVAX Major Shareholders INVA Major Shareholders DVAX Major Shareholders MNKD Major Shareholders OPK Major Shareholders GERN Major Shareholders ZBIO Major Shareholders RIGL Major Shareholders MYGN Major Shareholders This page (NASDAQ:LXRX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexicon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexicon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access